Compliance of patients with essential hypertension treated with Candesartan or Candesartan/hydrochlorothiazide - CoCa
Study identifier:NIS-CGE-ATA-2007/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Compliance of patients with essential hypertension treated with Candesartan or Candesartan/hydrochlorothiazide
Medical condition
essential hypertension
Phase
-
Healthy volunteers
No
Study drug
-
Sex
Unmapped
Actual Enrollment
1773
Study type
Observational
Age
None - None
Date
Study Start Date: 01 Jan 2007
Primary Completion Date: -
Study Completion Date: 01 Sept 2007
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Jan 2008 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 Patient with essential hypertension under treatment with candesartan or candesartan HCT | - |
Contacts
Investigators
Principal Investigator
R. E. Schmieder
University hospital Erlangen-Nurnberg
